Urology in New York

Fine Surgical Instruments, Inc. is a leading manufacturer and distributor of precision surgical instruments based in Hempstead, New York. The company supplies the global medical industry with an extensive range of high-quality surgical instruments across multiple specialties. Their comprehensive product portfolio includes diagnostic instruments, scalpels, scissors, forceps, needle holders, retractors, suturing instruments, and specialty tools for ophthalmology, ENT, gynecology, obstetrics, orthopedics, cardiology, urology, thoracic, neurosurgery, and bariatric procedures. Fine Surgical serves hospitals, surgical centers, and medical practitioners worldwide, offering both standard surgical instruments and specialized equipment for various surgical disciplines. The company provides an online catalog for procurement efficiency and maintains dedicated domestic and international sales teams.

Rigicon® Innovative Urological Solutions is a global manufacturer of advanced prosthetic urology solutions, specializing in penile implants, testicular prostheses, and related surgical instruments. The company designs and markets innovative medical devices for pelvic urology, including the Rigicon® Infla10® Three-piece Inflatable Penile Prosthesis (known for strong revision survival rates), malleable penile prostheses, and the HL-LEVINE Combo Prosthesis Tool for penile implant surgery. Rigicon also manufactures Artificial Urinary Sphincter (AUS) systems and testicular implants (both saline-filled and firm variants). The company provides comprehensive support to healthcare professionals through clinical studies, surgical training materials, product specifications, and technical documentation. Patient resources include recovery guides, educational materials on treatment options, and expert care locator services. Rigicon serves a global customer base across multiple regions including North America, Europe, Asia-Pacific, Middle East/North Africa, and Latin America, positioning itself as a trusted partner in advancing prosthetic urology practices worldwide.

Renalytix is an AI-enabled in vitro diagnostics company specializing in chronic kidney disease (CKD) management, particularly diabetic kidney disease (DKD). The company's flagship product, KidneyIntelX.dkd, combines proprietary AI algorithms with blood-based biomarker analysis, genetic data, and electronic health record integration to generate patient risk stratification scores for progressive kidney function decline. The test received FDA marketing authorization in Q2 2023 and Medicare coverage determination in June 2024. KidneyIntelX enables early identification of high-risk patients with type 2 diabetes and CKD stages 1-3b, allowing clinicians to optimize treatment targeting and resource allocation to slow or prevent disease progression. Renalytix operates CLIA-certified clinical laboratories and partners with major healthcare systems including Mount Sinai Health System, University of Michigan, and Singing River Health System. The company also provides biomarker discovery and drug development support services to pharmaceutical partners. With a focus on shifting kidney disease management from reactive treatment to proactive health optimization, Renalytix addresses a significant public health need affecting over 850 million people globally.

Ackermann Instrumente GmbH is a German manufacturer of precision surgical instruments, endoscopic systems, and minimally invasive surgery devices with over 70 years of industry experience. The company specializes in reusable hand instruments, rigid and flexible endoscopes, hybrid instruments, and complete endoscopy tower systems serving arthroscopy, laparoscopy, gynecology, urology, and ENT specialties. Product portfolio includes over 8,000 SKUs: arthroscopy instruments for small joint, shoulder, knee, and hip surgery with unique arthroscopic suturing and ACL/PCL reconstruction solutions; laparoscopic specialty instruments including XPress Lock™ Mini Lap line; comprehensive gynecological instrumentation for hysteroscopic and laparoscopic procedures; urology endoscopy sets featuring bipolar and laser resectoscopy; and ligature solutions including haemostatic titanium and polymer clips with appliers. Flagship visualization products include the NeoLite™ 4K UHD line with backside-illuminated CMOS sensors and Fusion ICG™ 4K UHD line with dual-sensor fluorescence technology. The company maintains ISO 13485:2016, US FDA, CFDA, ANVISA, and COFEPRIS certifications and operates expanded manufacturing facilities in Germany dedicated to instrument assembly. Comprehensive after-sales support includes product training, maintenance, repair, spare parts, warranty, and product return services. In-house R&D capabilities span device development through production.

Soteria Medical B.V. is a specialized medical device manufacturer focused on MRI-guided in-bore prostate biopsy solutions. The company has developed a proprietary Remote Controlled Manipulator (RCM)—a fully MRI-compatible robotic device for precision prostate interventions. The RCM enables real-time, near real-time targeting of suspicious prostate lesions within the MRI bore, significantly improving diagnostic accuracy for prostate cancer detection and reducing the need for multiple unnecessary biopsy cores. The RCM system addresses key clinical challenges: it delivers high diagnostic accuracy (reported 70% prostate cancer detection rates), reduces procedure duration (typically under 30 minutes), minimizes patient discomfort by eliminating general anesthesia, and improves specimen quality for pathological analysis. The device features intuitive planning software and remote needle-guide positioning, enabling radiologists to perform precise, guided biopsies with minimal patient motion and reduced in-bore time. Soteria Medical's technology has been validated by leading radiologists across multiple institutions in Europe (Spain, Italy, Netherlands, France, Norway), with testimonials emphasizing clinical safety, diagnostic efficiency, and positive patient experience compared to transrectal ultrasound (TRUS) guidance. The company's offering is positioned for hospital radiology departments and diagnostic imaging centers specializing in urologic oncology and prostate cancer diagnosis. Recent market recognition includes CMS introduction of dedicated CPT codes (55713, 55714) for in-bore MR-guided prostate biopsy, reflecting clinical differentiation and reimbursement support in the US market. Soteria Medical is an active participant in major medical imaging conferences (ECR).

Advanced Meditech International Inc., based in New York City since 1992, is a B2B supplier of surgical equipment and instruments designed to enhance safety, simplicity, and cost-effectiveness in medical practice. The company specializes in no-needle jet injection anesthesia devices (MadaJet systems), electrosurgery generators, thermal cautery equipment, ligating clips and appliers, sterilization and ultrasonic cleaning solutions, and PPE surgical masks. The MadaJet platform is available in multiple configurations for dental, general medical, urology, podiatry, and vasectomy applications, enabling local anesthesia delivery without needle injection. The company also distributes complementary surgical equipment from established manufacturers including Teleflex, Bovie, and Mada Medical. All products are rigorously tested and fully inspected before certification and shipment. Customer service is available 24/7 by phone, fax, and email.

LSI Solutions, Inc. is a medical device manufacturer specializing in innovative surgical instruments and suturing solutions for minimally invasive and open surgical procedures. The company develops proprietary devices for cardiac, general, gynecological, and urological surgery, with particular expertise in mitral valve repair and aortic valve replacement procedures. Their product portfolio includes the RAM (Rapid Annular Materialization) device—an automated titanium fastener system for annular suturing—and related instruments designed to enhance surgical precision, reduce operative time, and improve patient outcomes. LSI Solutions markets and distributes through a global network spanning North America, Europe, Asia-Pacific, the Middle East, and Latin America. The company maintains its global headquarters in Victor, New York, and demonstrates active engagement in surgical innovation through conference participation (AATS 2026, Re-Evolution Summit) and peer-reviewed research publications. Their device portfolio is positioned for cardiac surgeons performing endoscopic and minimally invasive procedures, with clinical evidence supporting safety, efficacy, and reduced complication rates (including lower infective endocarditis risk compared to hand-knot suturing). The company offers 24-hour technical support and maintains regulatory compliance appropriate for US medical device distribution.

GEOTEK Medical USA LLC is a medical device manufacturer specializing in minimally invasive diagnostic and therapeutic equipment, primarily serving urology and radiology disciplines. The company manufactures biopsy needles, disposable needle guides, and transperineal needle guide systems used in image-guided procedures. Founded in 2003, GEOTEK established its US operations office in New York in 2021. The company operates a certified production facility and holds FDA 510(k) clearance for its disposable needle guide products (obtained 2017), along with CE and ISO certifications (obtained 2009). Products are designed for precision needle placement in biopsy and therapeutic interventions, supporting both diagnostic imaging-guided and interventional procedures in urology and radiology departments.

Plymouth Medical is a Brooklyn-based orthobiologics and regenerative medicine company specializing in evidence-based products and services for healthcare providers across orthopedics, sports medicine, pain management, dermatology, plastics, regenerative esthetics, urology, and OBGYN. The company offers a comprehensive portfolio including platelet-rich plasma (PRP) systems, microfat grafting devices, analgesia systems, hemocytometers, wireless ultrasound probes, and microneedling devices. Beyond product distribution, Plymouth Medical provides clinical staff training, quality control services through PRP analysis and characterization (PAC), patient outcome tracking via the DataBiologics registry, and post-treatment rehabilitation support through digital remote therapeutic monitoring platforms. The company operates with a small core team supported by independent sales representatives across North America, emphasizing ethical guidelines and evidence-based practice in regenerative and orthobiologic treatments.